Flores ND

Idioma: Español
Referencias bibliográficas: 25
Paginas: 11-20
Archivo PDF: 520.50 Kb.

RESUMEN

La sarcopenia es de alta prevalencia en la población adulta mayor y aumenta conforme aumenta la edad, generando complicaciones en los pacientes como aumento en el riesgo de caídas y fracturas, aumento en la morbimortalidad y deterioro funcional. En Costa Rica no se cuenta con estudios de investigación en sarcopenia. Este estudio determina la prevalencia de sarcopenia en pacientes adultos mayores del Servicio de Hospital de Dia del Hospital Nacional de Geriatría y Gerontología en el II semestre de 2012. La población estudiada fue mayor de 70 años y la mayoría de los que consultaron fueron mujeres. El estudio de la prevalencia de la sarcopenia documentó un tercio de los pacientes con este síndrome y que aumentaba conforme aumenta la edad. Más de la mitad de los pacientes sarcopénicos tienen alto riesgo de caídas, un estado cognitivo normal y sin datos clínicos de depresión. Y un porcentaje algo alarmante de dependencia de las actividades de la vida diaria.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older peo-ple: an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 2009;13(10):881-889.

2. Cederholm, T., Bauer, J., Boirie Y., Schnei-der, S., et al., Toward a Definition of Sarco-penia. Clinics in Geriatric Medicine 27 (2011) 341-353.

3. Cruz, A., Baeyens, J., Bauer, J., et al. Sarco-penia: consenso europeo sobre su definición y diagnóstico. Informe del Grupo Europeo de trabajo sobre la sarcopenia en personas de edad avanzada. Age and ageing 39 (2010) 412-423.

4. Janssen, Ian. The Epidemiology of Sarcope-nia. Clinics in Geriatric Medicine 27 (2011) 355-363.

5. Desai, M, Bogardus, S., Williams, C., Vita-gliano G., Inouye, G. Development and Vali-dation of a Risk-Adjustment Index for Older Patients: The High-Risk Diagnoses for the Elderly Scale. Journal of American Geriatric Society 50:474-481, 2002.

6. Pillard, F., Laoudj-Chenivesse, D., Carnac G., Mercier, J., et al. Physical Activity and Sarcopenia. Clinics in Geriatric Medicine 27 (2011) 449-470.

7. Rolland, Y., Onder, G., Morley, J., Guillet-Guyonet, S., et al. Current and Future Phar-macologic Treatment of Sarcopenia. Clinics in Geriatric Medicine 27 (2011) 423-447.

8. Rosenberg, Irwin H., Sarcopenia: Origins and Clinical Relevance. Clinics in Geriatric Medicine 27 (2011) 337-339.

9. Thomas, David R. Sarcopenia. Clinics in Geriatric Medicine 27 (2011) 331-346.

10. Tinetti ME, Williams TF, Mayewski R, Fall Risk Index for elderly patients based on number of chronic disabilities. Am J Med 1986:80:429-434.

11. Visser, M., Schaap, L. Consequences of Sar-copenia. Clinics in Geriatric Medicine 27 (2011) 387-399.

12. Waters, Debra. L., Baumgartner Richard N. Sarcopenia and Obesity. Clinics in Geriatric Medicine 27 (2011) 401-421.

13. Walrand, S., Guillet, C., Salles, J., Cano, N., et al. Physiopathological Mechanism of Sar-copenia. Clinics in Geriatric Medicine 27 (2011) 365-385.

14. Rosenberg I. Summary comments: epidemio-logical and methodological problems in de-termining nutritional status of older persons. Am J Clin Nutr 1989; 50: 1231–3.

15. Rosenberg IH. Sarcopenia: origins and cli-nical relevance. J Nutr 1997; 127: 990S–91S.

16. Morley JE, Baumgartner RN, Roubenoff R et al. Sarcopenia. J Lab Clin Med 2001; 137: 231–43.

17. Inouye SK, Studenski S, Tinetti ME et al. Geriatric syndromes: clinical, research, and policy implications of a core geriatric con-cept. J Am Geriatr Soc 2007; 55: 780–91.

18. Olde Rikkert MG, Rigaud AS, van Hoeywe-ghen RJ et al. Geriatric syndromes: medical misnomer or progress in geriatrics? Neth J Med 2003; 61: 83–7.

19. Cruz-Jentoft A, Landi F, Topinková E et al. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010; 13: 1–7.

20. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predic-tors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 2002; 57: M772–7.

21. Chien MY, Huang TY, Wu YT. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Tai-wan. J Am Geriatr Soc 2008; 56: 1710–5.

22. Tanimoto Y, Watanabe M, Sun W. et al. Sar-copenia and falls in community-dwelling el-derly subjects in Japan: Defining sarcopenia according to criteria of the European Wor-king Group on Sarcopenia in Older People. Arch Gerontol Geriatr. 2014 May 4. pii: S0167-4943(14)00062-4

23. Vetrano DL, Landi F, Volpato S, et al. Asso-ciation of Sarcopenia With Short- and Long-term Mortality in Older Adults Admitted to Acute Care Wards: Results From the CRIME Study. J Gerontol A Biol Sci Med Sci. 2014 Apr 17

24. Alley DE, Shardell MD, Peters KW, et al. Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol A Biol Sci Med Sci. 2014 May;69(5):559-66.

25. Hsu YH, Liang CK, Chou MY, et al. Asso-ciation of cognitive impairment, depressive symptoms and sarcopenia among healthy ol-der men in the veterans retirement commu-nity in southern Taiwan: a cross-sectional study. Geriatr Gerontol Int. 2014 Feb;14 Suppl 1:102-8.